<DOC>
	<DOCNO>NCT00713258</DOCNO>
	<brief_summary>The primary objective trial show PTH ( 1-84 ) superior alendronate reduce back pain intensity 24-week treatment period postmenopausal woman osteoporosis related vertebral fracture ( ) . Secondly objective investigate difference patient report outcomes two treatment arm 24-week treatment period postmenopausal woman osteoporosis related vertebral fracture ( ) .</brief_summary>
	<brief_title>The Effect PTH ( 1-84 ) Alendronate Reduction Back Pain Postmenopausal Women With Osteoporosis Related Vertebral Fracture ( ) ( FP-005-IM )</brief_title>
	<detailed_description />
	<mesh_term>Back Pain</mesh_term>
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Spinal Fractures</mesh_term>
	<mesh_term>Fractures , Bone</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<mesh_term>Alendronate</mesh_term>
	<criteria>Postmenopausal woman Tscore â‰¤ 1.5 SD least one osteoporosis relate vertebral fracture . Chronic back pain . Previous/current treatment medical history .</criteria>
	<gender>Female</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>Postmenopausal woman</keyword>
	<keyword>Back pain</keyword>
	<keyword>Osteoporosis related fracture</keyword>
</DOC>